Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Drug Saf ; 38(2): 197-206, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25556085

RESUMO

BACKGROUND: Healthcare organizations, compendia, and drug knowledgebase vendors use varying methods to evaluate and synthesize evidence on drug-drug interactions (DDIs). This situation has a negative effect on electronic prescribing and medication information systems that warn clinicians of potentially harmful medication combinations. OBJECTIVE: The aim of this study was to provide recommendations for systematic evaluation of evidence for DDIs from the scientific literature, drug product labeling, and regulatory documents. METHODS: A conference series was conducted to develop a structured process to improve the quality of DDI alerting systems. Three expert workgroups were assembled to address the goals of the conference. The Evidence Workgroup consisted of 18 individuals with expertise in pharmacology, drug information, biomedical informatics, and clinical decision support. Workgroup members met via webinar 12 times from January 2013 to February 2014. Two in-person meetings were conducted in May and September 2013 to reach consensus on recommendations. RESULTS: We developed expert consensus answers to the following three key questions. (i) What is the best approach to evaluate DDI evidence? (ii) What evidence is required for a DDI to be applicable to an entire class of drugs? (iii) How should a structured evaluation process be vetted and validated? CONCLUSION: Evidence-based decision support for DDIs requires consistent application of transparent and systematic methods to evaluate the evidence. Drug compendia and clinical decision support systems in which these recommendations are implemented should be able to provide higher-quality information about DDIs.


Assuntos
Sistemas de Notificação de Reações Adversas a Medicamentos/normas , Sistemas de Apoio a Decisões Clínicas/normas , Interações Medicamentosas , Prescrição Eletrônica , Medicina Baseada em Evidências/normas , Bases de Dados Factuais , Rotulagem de Medicamentos , Guias de Prática Clínica como Assunto
2.
J Gen Intern Med ; 20(6): 541-5, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15987331

RESUMO

Placebo medication regimens may help educate students about adherence issues. In this randomized trial, 23 third-year medical students took a 2-week placebo regimen mimicking highly active antiretroviral therapy (HAART) during their medicine clerkship; 15 students served as controls. Although no effect was demonstrated from this intervention on an evaluation instrument examining attitudes and beliefs about medication nonadherence, all 23 student-subjects agreed in postintervention interviews that the experience was useful and had learning value. Representative comments from the 19 subjects who expanded their interview responses portray this intervention as an eye-opening and unique method for teaching students about medication adherence issues.


Assuntos
Terapia Antirretroviral de Alta Atividade , Estágio Clínico/métodos , Cooperação do Paciente , Assistência Centrada no Paciente/métodos , Placebos/uso terapêutico , Esquema de Medicação , Feminino , Infecções por HIV/tratamento farmacológico , Humanos , Masculino , Avaliação de Programas e Projetos de Saúde , Estudantes de Medicina , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...